Lonza Group AG (LZAGY)
Sector: Biotechnology
Industry: Biotechnology
Lonza Group AG
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 80.25 | 80.26 | 79.23 | 79.23 | 27,182 |
| Nov 13, 2026 | 79.47 | 79.51 | 79.17 | 79.25 | 26,807 |
| Nov 12, 2026 | 79.59 | 79.84 | 79.19 | 79.30 | 34,196 |
| Nov 11, 2026 | 79.36 | 80.04 | 79.32 | 79.75 | 34,049 |
| Nov 10, 2026 | 79.98 | 80.47 | 79.68 | 80.41 | 26,595 |
| Nov 9, 2026 | 80.78 | 81.33 | 80.07 | 81.06 | 42,098 |
| Nov 6, 2026 | 80.10 | 81.26 | 80.10 | 80.75 | 37,234 |
| Nov 5, 2026 | 82.16 | 82.63 | 81.64 | 81.90 | 126,681 |
| Nov 4, 2026 | 81.49 | 81.50 | 80.65 | 81.44 | 30,634 |
| Nov 3, 2026 | 79.09 | 79.77 | 79.05 | 79.21 | 29,254 |
| Nov 2, 2026 | 79.13 | 79.48 | 78.82 | 79.31 | 42,938 |
| Oct 30, 2026 | 78.50 | 78.78 | 77.67 | 77.84 | 25,023 |
| Oct 29, 2026 | 77.14 | 77.59 | 76.84 | 77.57 | 28,741 |
| Oct 28, 2026 | 75.10 | 76.30 | 75.08 | 75.92 | 44,972 |
| Oct 27, 2026 | 75.95 | 76.90 | 75.71 | 76.89 | 49,185 |
| Oct 26, 2026 | 76.72 | 76.74 | 76.33 | 76.56 | 22,036 |
| Oct 23, 2026 | 76.76 | 77.04 | 76.28 | 76.54 | 32,439 |
| Oct 22, 2026 | 76.50 | 76.85 | 76.20 | 76.69 | 128,719 |
| Oct 21, 2026 | 75.06 | 75.58 | 75.01 | 75.31 | 22,272 |
| Oct 20, 2026 | 75.65 | 76.17 | 75.40 | 75.94 | 20,323 |
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products.
It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions.
The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
based on 711.53M shares outstanding
30d Avg
41.20K
60d Avg
46.20K
90d Avg
45.53K
Lonza Group AG (OTC: LZAGY) traded at $79.23 on Nov 16, 2026, down 0.03% from the previous close of $79.25. 52-week range: $58.53 to $82.63. The company is in the Healthcare sector (Biotechnology).